130 related articles for article (PubMed ID: 9247772)
1. Serum hyaluronan levels follow disease activity in vasculitis.
West DC; Yaqoob M
Clin Nephrol; 1997 Jul; 48(1):9-15. PubMed ID: 9247772
[TBL] [Abstract][Full Text] [Related]
2. Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients.
Baskin E; Bakkaloglu A; Besbas N; Hascelik G; Saatci U; Gök F; Ozen S
Pediatr Nephrol; 2002 Nov; 17(11):917-9. PubMed ID: 12432434
[TBL] [Abstract][Full Text] [Related]
3. Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis.
Kümpers P; Horn R; Brabant G; Woywodt A; Schiffer M; Haller H; Haubitz M
Rheumatology (Oxford); 2008 Apr; 47(4):484-7. PubMed ID: 18281689
[TBL] [Abstract][Full Text] [Related]
4. Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.
Chen M; Wang F; Zhao MH
Rheumatology (Oxford); 2009 Apr; 48(4):355-8. PubMed ID: 19181656
[TBL] [Abstract][Full Text] [Related]
5. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist.
Gal AA; Velasquez A
Mod Pathol; 2002 Mar; 15(3):197-204. PubMed ID: 11904336
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of soluble adhesion molecules in patients with ANCA-associated vasculitis.
Di Lorenzo G; Pacor ML; Mansueto P; Lo Bianco C; Di Natale E; Rapisarda F; Pellitteri ME; Ditta V; Gioè A; Giammarresi G; Rini GB; Li Vecchi M
J Nephrol; 2004; 17(6):800-7. PubMed ID: 15593054
[TBL] [Abstract][Full Text] [Related]
8. Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides.
Terrier B; Saadoun D; Sène D; Ghillani P; Amoura Z; Deray G; Fautrel B; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Oct; 68(10):1564-71. PubMed ID: 18957481
[TBL] [Abstract][Full Text] [Related]
9. [The effect of plasmapheresis on cytokine serum levels and adhesion molecules in ANCA-positive renal vasculitis].
Tesar V; Jelínková E; Masek Z; Jirsa M; Zabka J; Bartůnková J; Stejskalová A; Janatková I
Cas Lek Cesk; 1997 Oct; 136(20):627-32. PubMed ID: 9490207
[TBL] [Abstract][Full Text] [Related]
10. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
Sinclair D; Stevens JM
Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
[TBL] [Abstract][Full Text] [Related]
12. Importance of checking anti-glomerular basement membrane antibody status in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis.
Gallagher JL; Sinha S; Reeve R; Kalra PA
Postgrad Med J; 2008 Apr; 84(990):220-2. PubMed ID: 18424581
[TBL] [Abstract][Full Text] [Related]
13. An index for renal outcome in ANCA-associated glomerulonephritis.
Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
[TBL] [Abstract][Full Text] [Related]
14. The clinical and pathological characteristics of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated small vessel vasculitis.
Wang Y; Zhao MH; Yu J; Xin G; Liu YC; Zhang YK; Wang HY
Exp Gerontol; 2004 Sep; 39(9):1401-5. PubMed ID: 15489063
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest.
Manicourt DH; Poilvache P; Nzeusseu A; van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 1999 Sep; 42(9):1861-9. PubMed ID: 10513800
[TBL] [Abstract][Full Text] [Related]
16. [Vasculitis and its renal manifestation with special reference to anti-neutrophil cytoplasmic antibody].
Minota S
Rinsho Byori; 2003 Mar; 51(3):231-8. PubMed ID: 12707996
[TBL] [Abstract][Full Text] [Related]
17. ANCA-negative pauci-immune renal vasculitis: histology and outcome.
Eisenberger U; Fakhouri F; Vanhille P; Beaufils H; Mahr A; Guillevin L; Lesavre P; Noël LH
Nephrol Dial Transplant; 2005 Jul; 20(7):1392-9. PubMed ID: 15855209
[TBL] [Abstract][Full Text] [Related]
18. ANCA and predicting relapse in systemic vasculitis.
Jayne DR; Gaskin G; Pusey CD; Lockwood CM
QJM; 1995 Feb; 88(2):127-33. PubMed ID: 7704563
[TBL] [Abstract][Full Text] [Related]
19. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
